1.
Loman N, Saghir H, Kimbung S. Predicting neoadjuvant chemotherapy treatment response in hormone- receptor-positive/HER2-negative breast cancer – results from the Swedish SCAN-B population-based cohort. AO [Internet]. 2025 Nov. 19 [cited 2026 May 30];64:1577-89. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/44201